LUX HEALTH TECH ACQUISITION - COM CL A (LUXA)

CUSIP: 55068A100

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM CL A
Total 13F shares
28,954,344
Share change
+1,730,056
Total reported value
$285,467,000
Put/Call ratio
84%
Price per share
$9.86
Number of holders
64
Value change
+$17,105,406
Number of buys
25
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q1 2022

As of 31 Mar 2022, LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,954,344 shares. The largest 10 holders included Empyrean Capital Partners, LP, Wolfswood Holdings, LLC, Weiss Asset Management LP, Senator Investment Group LP, MARSHALL WACE, LLP, RP Investment Advisors LP, MILLENNIUM MANAGEMENT LLC, Balyasny Asset Management LLC, D. E. Shaw & Co., Inc., and BANK OF MONTREAL /CAN/. This page lists 64 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.